T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Alcon
ALC
|
+$2.23B |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$1.45B |
| 3 |
Linde
LIN
|
+$1.44B |
| 4 |
American International
AIG
|
+$1.43B |
| 5 |
Marvell Technology
MRVL
|
+$1.31B |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$2.31B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.58B |
| 4 |
Eli Lilly
LLY
|
+$1.54B |
| 5 |
Booking.com
BKNG
|
+$1.17B |
Sector Composition
| 1 | Technology | 18.89% |
| 2 | Healthcare | 16.97% |
| 3 | Financials | 13.8% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTSV
1351
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $7.52M | ﹤0.01% |
709,796
+14,591
| +2% | +$155K |
|
|
FDC
1352
DELISTED
First Data Corporation
FDC
| $7.44M | ﹤0.01% |
274,945
+25,339
| +10% | +$686K |
|
|
WW
1353
DELISTED
WW International
WW
| $7.3M | ﹤0.01% |
382,189
-134
| -0% | -$2.56K |
|
1354
Omega Healthcare
OHI
$12.5B
| $7.26M | ﹤0.01% |
197,439
+134,402
| +213% | +$4.94M |
|
|
PGNX
1355
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $7.11M | ﹤0.01% |
1,151,552
+980,574
| +574% | +$6.05M |
|
|
STAY
1356
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $7.05M | ﹤0.01% |
417,362
-4,975
| -1% | -$84K |
|
1357
Zymeworks
ZYME
$1.19B
| $6.68M | ﹤0.01% |
+303,421
| New | +$6.68M |
|
|
AZUL
1358
DELISTED
Azul
AZUL
| $6.65M | ﹤0.01% |
198,888
-588,773
| -75% | -$19.7M |
|
1359
Annaly Capital Management
NLY
$14.1B
| $6.64M | ﹤0.01% |
181,801
+1,656
| +0.9% | +$60.5K |
|
1360
Adverum Biotechnologies
ADVM
$63.4M
| $6.64M | ﹤0.01% |
+55,804
| New | +$6.64M |
|
|
EXTN
1361
DELISTED
Exterran Corporation
EXTN
| $6.61M | ﹤0.01% |
464,576
-377,301
| -45% | -$5.37M |
|
1362
Corvus Pharmaceuticals
CRVS
$434M
| $6.59M | ﹤0.01% |
1,762,248
-203,794
| -10% | -$762K |
|
|
SASR
1363
DELISTED
Sandy Spring Bancorp Inc
SASR
| $6.44M | ﹤0.01% |
184,592
-428,221
| -70% | -$14.9M |
|
1364
Wolfspeed
WOLF
$365M
| $6.4M | ﹤0.01% |
113,866
-266
| -0.2% | -$14.9K |
|
1365
Columbia Financial
CLBK
$1.6B
| $6.39M | ﹤0.01% |
+423,340
| New | +$6.39M |
|
1366
Puma Biotechnology
PBYI
$225M
| $6.34M | ﹤0.01% |
498,609
-287,356
| -37% | -$3.65M |
|
1367
Arch Capital
ACGL
$34.4B
| $6.24M | ﹤0.01% |
168,296
+19,053
| +13% | +$706K |
|
1368
Cibus
CBUS
$71.5M
| $6.2M | ﹤0.01% |
9,934
-10,740
| -52% | -$6.7M |
|
1369
Toll Brothers
TOL
$13.8B
| $6.2M | ﹤0.01% |
169,251
+17
| +0% | +$623 |
|
1370
SI-BONE Inc
SIBN
$677M
| $6.14M | ﹤0.01% |
301,793
-432,836
| -59% | -$8.8M |
|
|
ZAYO
1371
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $6.08M | ﹤0.01% |
184,864
-179,123
| -49% | -$5.9M |
|
1372
Berkshire Hathaway Class A
BRK.A
$1.06T
| $6.05M | ﹤0.01% |
19
-1
| -5% | -$318K |
|
1373
Sunrun
RUN
$3.71B
| $6.04M | ﹤0.01% |
+321,925
| New | +$6.04M |
|
1374
LendingClub
LC
$1.91B
| $5.93M | ﹤0.01% |
361,716
+37,793
| +12% | +$620K |
|
1375
STRATTEC Security
STRT
$283M
| $5.9M | ﹤0.01% |
244,961
+200
| +0.1% | +$4.82K |
|